Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Low-dose Hydrocortisone in Septic Shock
NCT02580240Completed
- Sponsor
- Subei People's Hospital
- Start
- Sep 2015
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in septic shock comparing Placebo with Hydrocortisone (2 arms). Primary endpoint: 28-day Mortality. Started Sep 2015; status: completed.
02
Drugs
hydrocortisone
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT02580240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02580240.